Novavax Reports Fourth Quarter and Year-End 2018 Financial Results

NEXT STORY
FDA approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer
PREV STORY
Evolus Reports Fourth Quarter and Full Year 2018 Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Market Research Finds 99% Of US Clinical Cardiologists Surveyed Report a High Unmet Need for New Innovative Drug Treatments for Early Cardiogenic Shock Patients (ECS) as Windtree Therapeutics Prepares for Clinical Results from its Istaroxime ECS Study

author_avatar
NASDAQ Market News

LifeSave Transport Announces Hiring Push for Flight Nurses and Medics

author_avatar
NASDAQ Market News

VigiLanz Integrates Infectious Disease Content from Sanford Guide

MINNEAPOLIS, MN--(Marketwired - Nov 29, 2017) - VigiLanz, a digital healthcare intelligence firm, announced ...

author_avatar
NASDAQ Market News